Lotus Eye Hospital and Institute Gestione
Gestione criteri di controllo 4/4
Lotus Eye Hospital and Institute Il CEO è Kuttapalayam Ramalingam, nominato in Aug2020, ha un mandato di 4.25 anni. possiede direttamente 1.43% delle azioni della società, per un valore di ₹ 20.02M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 4.2 anni e 3.8 anni.
Informazioni chiave
Kuttapalayam Ramalingam
Amministratore delegato
₹1.2m
Compenso totale
| Percentuale dello stipendio del CEO | n/a |
| Mandato del CEO | 4.3yrs |
| Proprietà del CEO | 1.4% |
| Durata media del management | 4.2yrs |
| Durata media del Consiglio di amministrazione | 3.8yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Optimistic Investors Push Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) Shares Up 25% But Growth Is Lacking
Aug 21
Lotus Eye Hospital and Institute Limited's (NSE:LOTUSEYE) Price Is Out Of Tune With Earnings
Jan 24Lotus Eye Hospital and Institute's (NSE:LOTUSEYE) Dividend Will Be ₹0.50
Sep 08We Ran A Stock Scan For Earnings Growth And Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Passed With Ease
Jul 15Here's Why Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Has Caught The Eye Of Investors
Apr 07We Ran A Stock Scan For Earnings Growth And Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Passed With Ease
Oct 08Lotus Eye Hospital and Institute's (NSE:LOTUSEYE) Dividend Will Be ₹0.50
Sep 02If EPS Growth Is Important To You, Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Presents An Opportunity
Jun 17MD & Whole Time Director Sangeetha Sundaramoorthy Just Bought 2.8% More Shares In Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)
Mar 11Chief Executive Officer K. Ramalingam Just Bought 122% More Shares In Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)
Dec 30Insider Buying: The Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) MD & Whole Time Director Just Bought 2.8% More Shares
Nov 20The Chief Executive Officer of Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE), K. Ramalingam, Just Bought 17% More Shares
Sep 21Why Investors Shouldn't Be Surprised By Lotus Eye Hospital and Institute Limited's (NSE:LOTUSEYE) P/E
Aug 27
Should You Take Comfort From Insider Transactions At Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)?
Aug 03Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) P/E Isn't Throwing Up Surprises
Jul 06AMMINISTRATORE DELEGATO
Kuttapalayam Ramalingam (74 yo)
4.3yrs
Mandato
₹1,200,000
Compensazione
Dr. Kuttapalayam Songappan Ramalingam, M.D., serves as an Executive Director at Lotus Eye Hospital and Institute Limited since February 10, 2021. Dr. Ramalingam serves as Chief Executive Officer at Lotus E...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO & Executive Director | 4.3yrs | ₹1.20m | 1.43% ₹ 20.0m | |
| Chief Financial Officer | 2.5yrs | ₹1.70m | Nessun dato | |
| Company Secretary & Compliance Officer | 2.8yrs | ₹1.08m | Nessun dato | |
| MD & Director | 4.2yrs | ₹3.09m | 18.84% ₹ 262.9m | |
| Vice President of Administration | 6.5yrs | Nessun dato | 0% ₹ 0 |
4.2yrs
Durata media
67yo
Età media
Gestione esperta: Il team dirigenziale di LOTUSEYE è considerato esperto (durata media dell'incarico 4.2 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO & Executive Director | 3.8yrs | ₹1.20m | 1.43% ₹ 20.0m | |
| MD & Director | 5yrs | ₹3.09m | 18.84% ₹ 262.9m | |
| Vice President of Administration | 4.8yrs | Nessun dato | 0% ₹ 0 | |
| Chairman of the Board | 8.5yrs | ₹150.00k | 18.78% ₹ 262.0m | |
| Independent Director | 3.8yrs | ₹200.00k | Nessun dato | |
| Independent Non-Executive Director | 1.9yrs | ₹200.00k | Nessun dato | |
| Independent Non-Executive Director | 1.8yrs | ₹175.00k | Nessun dato |
3.8yrs
Durata media
61yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di LOTUSEYE sono considerati esperti (durata media dell'incarico 3.8 anni).